SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-097291
Filing Date
2024-08-14
Accepted
2024-08-14 18:00:17
Documents
2
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1616
2 EX-24.1 - POWER OF ATTORNEY itci-ex24_1.htm EX-24.1 11016
  Complete submission text file 0000950170-24-097291.txt   14114
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address
Narula Sanjeev (Reporting) CIK: 0001820590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36274 | Film No.: 241209906